Loading clinical trials...
Loading clinical trials...
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
Conditions
Interventions
Recombinant human soluble IL-4 receptor
Placebo for Recombinant human soluble IL-4 receptor
Start Date
May 1, 1998
Primary Completion Date
February 1, 2000
Completion Date
February 1, 2000
Last Updated
March 7, 2016
NCT07219173
NCT02327897
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions